Centre Hospitalier National d'Ophtalmologie des 15/20, Service du Pr. NORDMANN, Paris, France.
Eye (Lond). 2019 Jun;33(6):902-909. doi: 10.1038/s41433-019-0336-z. Epub 2019 Jan 24.
BACKGROUND/OBJECTIVES: To assess the risk of immediate sudden visual loss ("wipe-out" phenomenon) following non-penetrating deep sclerectomy (NPDS) for end-stages glaucoma within the first 6-months postoperative period.
SUBJECTS/METHODS: Monocenter database study. We reviewed the results for 73 eyes with severe or end-stage glaucoma that underwent NPDS. End-stage glaucoma (stage 5) was defined by the inability of patients to perform the Humphrey visual field test or by a visual acuity <20/200 due to glaucoma, according to the Glaucoma Staging System classification. Severe glaucoma (stage 4) was defined by a mean deviation (MD) <-20 dB by the preoperative 24-2 Humphrey visual field assessment. All eyes had a severe defect on the central 10° visual field: only a central island of vision remained. "Wipe-out" was defined as the permanent postoperative reduction of visual acuity to <20/200 or to "counting fingers" or less if preoperative visual acuity was <20/200.
The mean age was 60 years (range 22-86). Before surgery, the average MD (Humphrey 24-2) was -25.6 ± 3.8 dB, the MD (Humphrey 10-2) -19.9 ± 7.0 dB, and the VFI 24.6 ± 13%. There were no cases of postoperative flat anterior chamber. No patients experienced "wipe-out" within the first 6 months following surgery. At the six-month visit, intraocular pressure (IOP) had decreased significantly from 22.0 ± 8.8 to 13.5 ± 4.5 mmHg (P<0.001). There were no significant changes in mean visual acuity after 6 months (P = 6).
In our study, NPDS provided considerable IOP decrease with no occurrences of "wipe-out" and few other complications. Consideration of NPDS in end-stage and severe glaucoma is advisable given its low risk of intraoperative and postoperative complications and the low risk of wipe out. This surgery should probably be offered with less apprehension about the risk of "wipe-out" in end-stages glaucoma.
背景/目的:评估非穿透性深层巩膜切除术(NPDS)治疗晚期青光眼后前 6 个月内发生即时突发性视力丧失(“抹消”现象)的风险。
对象/方法:单中心数据库研究。我们回顾了 73 只患有严重或晚期青光眼的眼睛的结果,这些眼睛均接受了 NPDS 治疗。晚期青光眼(第 5 期)根据 Glaucoma Staging System 分类,定义为患者无法进行 Humphrey 视野测试或因青光眼导致视力<20/200。严重青光眼(第 4 期)定义为术前 24-2 Humphrey 视野评估的平均偏差(MD)<-20dB。所有眼睛的中央 10°视野都有严重缺陷:仅留有中央视岛。“抹消”定义为术后永久性视力下降至<20/200 或术前视力<20/200 时降至“指数”或更差。
平均年龄为 60 岁(范围 22-86 岁)。手术前,平均 MD(Humphrey 24-2)为-25.6±3.8dB,MD(Humphrey 10-2)为-19.9±7.0dB,VFI 为 24.6±13%。术后无浅前房病例。术后 6 个月内无 1 例发生“抹消”。在 6 个月的随访中,眼内压(IOP)从 22.0±8.8mmHg 显著下降至 13.5±4.5mmHg(P<0.001)。6 个月后平均视力无明显变化(P=0.6)。
在我们的研究中,NPDS 显著降低了眼压,且未发生“抹消”和其他并发症。考虑到 NPDS 术中及术后并发症风险低,“抹消”风险低,建议对晚期和严重青光眼患者使用 NPDS。在晚期青光眼的治疗中,对“抹消”风险的担忧可能会减少。